Pritty Patel provides global leadership and direction in developing Labcorp Central Laboratory Services’ capabilities in clinical microbiology for anti-infective studies while also leading the continuous development of the science, strategy and breadth of departmental capabilities. She continues to develop and implement scientific and business strategy for Labcorp Central Labs’ global clinical microbiology laboratories for Phase II and III clinical trials. Additionally, Pritty is responsible for implementing quality action plans.
Pritty has more than 20 years of experience in microbiology and related fields, while achieving significant improvements in delivery and quality of testing services for clients. She presents numerous abstracts and other presentations at industry conferences on microbiology and related topics. Pritty is a member of the American Society for Microbiology and the South Central Association for Clinical Microbiology. She joined Labcorp Drug Development in 2001.
Area of Expertise: Clinical Trials, Molecular Infectious Disease, Molecular Microbiology, Routine Microbiology
Memberships: ASM member
PUBLICATIONS:
1. Edward J. Bottone, Lina Patel, Pritty Patel and Thomas Robin - Mucoid Encapsulated Enterococcus faecalis: An Emerging Morphotype Isolated from Patients with Urinary Tract Infections Diagnostic Microbiology and Infectious Disease Journal v31, i3, p429-430
2. Susanne Paukner; Lisa Goldberg; Elizabeth Alexander; Anita F.Das; Stefanie Heinrich; Pritty Patel; Gregory J.Moran; Christian Sandrock; Thomas M.FileJr; Jorge E.Vidal; iKen B.Waites; Steven P.Gelone and Jennifer Schranz - Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin Journal of Global Antimicrobial Resistance m5G; December 18, 2021;15:32 https://doi.org/10.1016/j.jgar.2021.10.021
Webinar:
YOUR PRESCRIPTION FOR AN EFFICIENT INFECTIOUS DISEASE STUDY Rich Science and Seamless Operations - October 21, 2015.
http://www.slideshare.net/covance/the-prescription-for-a-healthy-infectious-disease-clinical-trial-rich-science-seamless-operations
Abstracts & Presentations:
1. Patel, P., Wegerhoff, FO. Newton, L., Oefinger, PE. Comparison of five transport media for the extended maintenance of viability of aerobes and anaerobes. Abstracts: 104th ASM General Meeting, New Orleans, 2004
2. Patel, P., Wegerhoff, FO. Comparison of Two Commercial Systems for the Rapid Identification of Non-fermenting Gram-negative Bacteria Abstracts: 105th ASM General Meeting, Atlanta, 2005.
3. P. P. Patel, S. K. Gordon, F. O. Wegerhoff; Comparison of Two Different Media to Maintain Viability of Ocular Pathogens Transported at Different Temperatures Abstracts: 106th ASM General Meeting, Florida, 2006.
4. P. P. Patel, F. O. Wegerhoff; Maintenance of viability of Ocular Pathogens during Transport from Remote Locations. Abstracts: 107th ASM General Meeting, Toronto Canada, 2007.
5. P. P. Patel, F. O. Wegerhoff; Maintenance of the Viability of Lactobacillus Species Transported in A.C.T. I Under Different Temperature Conditions. Abstracts: 108th ASM General Meeting, Boston, MA, 2008.
6. P. P. Patel, A.M.Kimberlin, F. O. Wegerhoff; Identification of Roseomonas mucosa recovered from patients with Blepharoconjunctivitis. Abstracts: 109th ASM General Meeting, Philadelphia, PA, 2009.
7. P. P. Patel, F.O.Wegerhoff; “Molecular identification of some unusual bacteria associated with lower respiratory tract infections”. Abstracts: 110th ASM General Meeting, San Diego, CA, 2010.
8. C. Hill, P.E. Oefinger, J. Emerson, M.B. Binder, P. Patel, L. Decker; Comparison of Three Immunoassays for Measurement of Anti double stranded DNA Levels. Abstracts: AACC Annual meeting, Atlanta GA, 2011.